W. Long

发表

Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial

J. H. Diehl, R. Barst, M. Mcgoon, 1990 .

FOR THE PRIMARY PULM HYPERTENSION STUDY GROUP. A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY HYPERTENSION

R. Barst, L. Rubin, W. Long, 1996 .

Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.

B. Groves, D. Stewart, R. Barst, 1999, Circulation.

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.

B. Groves, B. Brundage, C. Keller, 1997, Circulation.

Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension

G. Koch, B. Brundage, C. Keller, 1997 .

Prostacyclin and PGE1 treatment of pulmonary hypertension.

L. Rubin, W. Long, 1987, The American review of respiratory disease.

CORRELATION OF ACUTE PROSTACYCLIN RESPONSE IN PRIMARY (UNEXPLAINED) PULMONARY HYPERTENSION WITH EFFICACY OF TREATMENT WITH CALCIUM CHANNEL BLOCKERS AND SURVIVAL

B. Groves, D. Badesch, N. Voelkel, 1993 .

Obstructing balloon catheter for the induction of systolic hypertension in the pulmonary ventricle—an acute hemodynamic study in the piglet

P. Bonhoeffer, C. Lucas, H. Katayama, 1992, Cardiology in the Young.

Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension.

H. Palevsky, A. Fishman, J. Crow, 1990, Circulation.

Childhood traumatic infarction causing left ventricular aneurysm: diagnosis by two-dimensional echocardiography.

P. W. Willis, G. W. Henry, W. Long, 1985, Journal of the American College of Cardiology.

Prostacyclin inAcuteRespiratory Failure inCOPD

J. Crow, W. Long, K. Weir, 2017 .

Developmental aspects of the effect of naloxone on control of breathing in piglets.

E. Lawson, W. Long, 1983, Respiration physiology.

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

B. Groves, B. Brundage, C. Keller, 1996, The New England journal of medicine.

Long-term continuous prostacyclin treatment improves survival in primary pulmonary hypertension

R. Barst, M. Mcgoon, L. Rubin, 1993 .

Comparative AcuteEffects ofAdenosine andProstacyclin inPrimary Pulmonary Hypertension

R. Vestal, E. Kaufmann, W. Long, 2017 .

Maternal lithium and neonatal Ebstein's anomaly: evaluation with cross-sectional echocardiography.

P. W. Willis, W. Long, 1984, American journal of perinatology.

Radionuclide diagnosis of infradiaphragmatic total anomalous pulmonary venous drainage

J. Perry, H. S. Harned, E. Lawson, 1985, Pediatric Cardiology.

2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPA

N. Assy, Z. Younossi, E. Zuckerman, 2010 .

Clinical Manifestations of Congenital Syphilitic Hepatitis: Implications for Pathogenesis

E. Lawson, M. Ulshen, W. Long, 1984, Journal of pediatric gastroenterology and nutrition.

Structural cardiovascular abnormalities presenting as persistent pulmonary hypertension of the newborn.

W. Long, 1984, Clinics in perinatology.

Cerebral arteriovenous malformation presenting as persistent fetal circulation. Diagnosis by cross-sectional echo.

G. W. Henry, W. Long, S. Schall, 1984, American journal of perinatology.

Pleural effusion in the first days of life: a prospective study.

H. S. Harned, E. Lawson, E. Kraybill, 1984, American journal of perinatology.

Hemodynamic effects of endothelin-1 in the newborn piglet: influence on pulmonary and systemic vascular resistance.

H. Katayama, W. Long, W. Henry, 1991, Journal of cardiovascular pharmacology.

Interaction of excitatory and inhibitory respiratory afterdischarge mechanisms in piglets.

E. Lawson, W. Long, 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

G. Koch, T. Schwartz, W. Summer, 2002, Journal of the American College of Cardiology.

Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.

S. Rich, R. Vestal, E. Kaufmann, 1995, Chest.

Screening Agents for Acute Pulmonary Vasodilator Responsiveness in Primary Pulmonary Hypertension

Harold, A. Fishman, J. Crow, 2005 .

Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension.

G. Koch, W. Summer, A. Hinderliter, 2003, The American journal of cardiology.

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.

G. Koch, W. Summer, A. Hinderliter, 1999, The American journal of cardiology.

Neurotransmitters and biphasic respiratory response to hypoxia.

E. Lawson, W. Long, 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.

J. Ghali, M. Koren, James R. Taylor, 2006, The Journal of clinical endocrinology and metabolism.

Central origin of biphasic breathing pattern during hypoxia in newborns.

E. Lawson, W. Long, Edward E. Lawson, 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD.

S. Archer, E. K. Weir, J. Crow, 1996, Chest.

CONIVAPTAN, A NOVEL ARGININE VASOPRESSIN ANTAGONIST, PRODUCED AQUARESIS AND INCREASED SERUM SODIUM CONCENTRATION IN PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA.: 234-T

J. Verbalis, J. Ghali, P. Gross, 2005 .

446 TIMING AND FREQUENCY OF DEPRESSION DURING HCV-TREATMENT WITH CONTROLLED-RELEASE-IFNA2B (CR2B) VS. PEGYLATED-IFNA2B (PEG2B): RESULTS FROM SELECT-2, A RANDOMIZED-OPEN-LABEL-72-WEEK-COMPARISON IN 116 TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 HCV

Z. Younossi, S. Stoinov, E. Lawitz, 2011 .